
Neoliv Pharma Private Limited
About Neoliv Pharma Private Limited
Data last updated:
Neoliv Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 08 May 2015.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC098831.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Mridula Lokireddy and Vemireddy Krishna Tulasi.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Plot No.58 To 61 Flat No.502 Phase – II Innova Residency Mythri Nagar Madinaguda, Hyderabad, Telangana, India – 500050.
Company details
Contact details
Neoliv Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.58 To 61 Flat No.502 Phase – II Innova Residency Mythri Nagar Madinaguda, Hyderabad, Telangana, India – 500050
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Neoliv Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neoliv Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Neoliv Pharma Private Limited, buy the company report.
Financials of Neoliv Pharma Private Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Neoliv Pharma Private Limited, buy the company report.
Board of directors of Neoliv Pharma Private Limited
Neoliv Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mridula Lokireddy | Director | 08 May 2015 | 11 Years 5 Months | As last reported |
| Vemireddy Krishna Tulasi Also directs: Jaasvin Pharmaceuticals Private Limited | Director | 08 May 2015 | 11 Years 5 Months | As last reported |
| Deepika Kallam | Director | 08 May 2015 | 11 Years 5 Months | As last reported |
Auditor
Neoliv Pharma Private Limited is audited by PRAVEEN BABU AKINAPALLY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAVEEN BABU AKINAPALLY | FY 2017 | 222333 |
Shareholding
The shareholding of Neoliv Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Neoliv Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neoliv Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neoliv Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Neoliv Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Neoliv Pharma Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Deepika Kallam was appointed as Director on 08 May 2015.
Frequently asked questions
Neoliv Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Neoliv Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 08 May 2015 and is registered under CIN U24100TG2015PTC098831. The company has been struck off by the Registrar of Companies and is no longer operational.
Neoliv Pharma had 3 directors:
- Mridula Lokireddy - Director
- Vemireddy Krishna Tulasi - Director
- Deepika Kallam - Director
The CIN (Corporate Identification Number) of Neoliv Pharma is U24100TG2015PTC098831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Neoliv Pharma is at Plot No.58 To 61 Flat No.502 Phase – II Innova Residency Mythri Nagar Madinaguda, Hyderabad, Telangana, India – 500050.
Neoliv Pharma was incorporated on 08 May 2015. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Neoliv Pharma on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2016 are in the company report.
Neoliv Pharma operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Deepika Kallam was appointed as Director on 08 May 2015. Mridula Lokireddy was appointed as Director on 08 May 2015. Vemireddy Krishna Tulasi was appointed as Director on 08 May 2015.
The compliance status of Neoliv Pharma is compliant as of 05 July 2026.

